Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,910 JPY | +1.66% | +6.07% | -9.26% |
Apr. 08 | Kusuri No Aoki’s Profit Down 31% in Fiscal Q1-Q3 | MT |
Feb. 28 | Japan retailer Aeon to merge with drugstore chains Tsuruha and Welcia | RE |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- With regards to fundamentals, the enterprise value to sales ratio is at 0.73 for the current period. Therefore, the company is undervalued.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The company does not generate enough profits, which is an alarming weak point.
- The company is not the most generous with respect to shareholders' compensation.
- For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
Ratings chart - Surperformance
Sector: Drug Retailers
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-9.26% | 1.75B | - | ||
-11.64% | 3.62B | D+ | ||
-0.09% | 3.36B | D- | ||
-23.44% | 3.06B | D | ||
+7.56% | 2.67B | - | ||
+9.74% | 2.59B | C+ | ||
+9.30% | 1.35B | - | - | |
-18.45% | 957M | - | ||
-38.18% | 704M | - | - | |
-1.85% | 370M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 3549 Stock
- Ratings Kusuri No Aoki Holdings Co., Ltd.